It was, however, more recently reported that the SDN-1 syndecan, a somatic transmembrane proteoglycan, affected glp-1 /Notch signalling, but regulation was found to occur at the level of receptor expression 58
Based on the recorded data, none of the patients included in the present study had 3 of the 5 diagnostic criteria of metabolic syndrome
The search included articles published between 2010 and 2025, using keywords: Parkinsons disease, -synuclein, dopaminergic degeneration, ferroptosis, deep brain stimulation, stem cell therapy, and AI in PD diagnosis. Results: The review highlights a multifactorial etiology involving -synuclein pathology, oxidative stress, mitochondrial dysfunction, genetic mutations (SNCA, LRRK2, VPS35), environmental toxins, and gut dysbiosis
Neuron, 2012
[25] [26] It's worth noting that most clinical trials of GLP-1 medications excluded patients with significant active gastrointestinal disease, creating an evidence gap for those with severe or poorly controlled IBD
Comprehensive stool analysis: Evaluating the gut microbiome and digestive function can provide insights into potential imbalances that may contribute to histamine intolerance or impaired DAO function
